As more Americans turn to weight loss drugs, the U.S. adult obesity rate​ is declining, according to new survey data from ...

UPS, in the throes of a cost-cutting drive, said Tuesday that it had reduced its workforce by 48,000 employees this year. The ...

Researchers investigating drugs such as Ozempic and Mounjaro have discovered a crucial detail about how they affect alcohol ...

PHOENIX -- Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, ...

Preliminary studies suggest GLP-1s may offer long-term protection against the eye disease AMD for people without diabetes.

Somehow, it’s becoming even harder to get a GLP-1.

A Gallup poll suggests nearly 8 million fewer people are obese than in 2022 — a drop that coincides with the surging use of ...

Diabetes has reached an all-time high despite a “statistically meaningful decrease” in the adult obesity rate, Gallup ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

GLP-1 receptor agonists show promise in treating various chronic conditions, but potential risks and unanswered questions remain for care of patients with NETs.

The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

LOUISVILLE, KY. — A panel representing retail and food processing discussed consumer insights at the recent American Egg Board and United Egg Producers annual joint executive conference in Louisville, ...